医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

FIGS Announces Date of Second Quarter 2024 Earnings Release, Conference Call and Webcast

2024年07月26日 AM05:05
このエントリーをはてなブックマークに追加


 

SANTA MONICA, Calif.

FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its second quarter 2024 financial results on Thursday, August 8, 2024, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a second quarter 2024 financial highlights presentation on its investor relations website at https://ir.wearfigs.com/financials/quarterly-results/default.aspx.

FIGS Second Quarter 2024 Earnings and Conference Call

Date: Thursday, August 8, 2024

Time: 2:00 p.m. PT / 5:00 p.m. ET

Live Call: (833) 470-1428 (US) or +1 404 975 4839 (International)

  • Conference ID: 061510

Replay: (866) 813-9403 (US) or +1 929 458 6194 (International)

  • Conference ID: 632451
  • The replay will be available from approximately two hours after the completion of the live call until 11:59 pm ET on August 15, 2024

Webcast: https://ir.wearfigs.com/events-and-presentations/events/default.aspx

Disclosure Information

FIGS uses the ir.wearfigs.com website, as well as press releases, filings with the U.S. Securities and Exchange commission and public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the public and for complying with our disclosure obligations under Regulation FD.

About FIGS

FIGS is a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower and serve current and future generations of healthcare professionals. We create technically advanced apparel and products that feature an unmatched combination of comfort, durability, function and style. We share stories about healthcare professionals’ experiences in ways that inspire them. We build meaningful connections within the healthcare community that we created. Above all, we seek to make an impact for our community, including by advocating for them and always having their backs.

We serve healthcare professionals in numerous countries in North America, Europe, the Asia Pacific region and the Middle East. We also serve healthcare institutions through our TEAMS platform.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240725021413/en/

CONTACT

Investors:

Bruce Williams & Dawn Francfort

ICR, Inc.

IR@wearfigs.com

Media:

Todd Maron

press@wearfigs.com

同じカテゴリーの記事 

  • Ifinatamab Deruxtecan Continues to Demonstrate Promising Objective Response Rates in Patients with Extensive-Stage Small Cell Lung Cancer in IDeate-Lung01 Phase 2 Trial
  • Huonslab Announces Positive Results from In Vivo comparative PK study of Trastuzumab/HyDIFFUZETM compared with marketed rHuPH20 co-formulation with Trastuzumab
  • Rapid Medical™、TIGERTRIEVER™13を用いたDISTALS臨床試験の中間安全性解析で、中血管閉塞の安全性の懸念がないことを報告
  • Amneal and Shilpa Announce U.S. FDA Approval of BORUZU™, the First Ready-to-Use Version of Bortezomib for subcutaneous administration
  • JCR Pharmaceuticals’ Data Presentations at SSIEM Annual Symposium 2024 Highlight Investigational Treatments for Lysosomal Storage Disorders